Navigation Links
New England Peptide Implements Quality Management System, Prepares for ISO 9001: 2008 Registration

New England Peptide, LLC (NEP), is developing a formal quality management system at its Gardner, Mass., facility, focusing on continuous process improvement and customer satisfaction.

Gardner, Mass. (PRWEB) July 15, 2008 -- New England Peptide, LLC (NEP), is developing a formal quality management system at its Gardner, Mass., facility, focusing on continuous process improvement and customer satisfaction.

The program is designed to help NEP ensure that the company continues to offer the best quality and service possible in the industry, says Dave Robinson, NEP's CEO, while preparing for potential ISO 9001:2008 Quality Management System Registration.

The ISO 9000 family of standards represents an international consensus on quality management practices. The ISO 9001:2008 standard provides a tried and tested framework for taking a systematic approach to managing an organization's processes so that they consistently turn out product that satisfies customers' expectations.

In the implementation of the system, NEP will document and standardize all quality control processes and procedures involved in manufacture of the company's products, from customer inquiry through shipment, in line with ISO's rigorous criteria. All employees will undergo training in policies, procedures, and work instructions that are compliant with ISO quality documents. Selected NEP personnel will conduct internal audits at the end of the process.

The formal system and process will help assure the most efficient operations and top-quality customer service, says Robinson, by taking steps to move through the quality process as expediently as possible, continually work to tighten standards and systems, and quickly identify and correct any issues that arise in day-to-day operations. "It's running a smart business," he states.

NEP will integrate the quality system with its PepTrend© knowledge base software. PepTrend facilitates the design, synthesis, and production of synthetically made peptides by incorporating data harnessed though each peptide production run with decades worth of proven peptide chemistry knowledge and trends. New standard operating procedures built upon PepTrend's best practices will allow NEP's production team to apply solutions to unique coupling challenges faster than ever, according to Robinson, resulting in increased yields, decreased turnaround time, further enhancement of on-time delivery and order accuracy, and greater reductions in scrap rate.

The quality system also complements NEP's lean manufacturing program, now in process at the company's facility, adds Robinson. Lean manufacturing also focuses on continuous improvement, helping companies standardize best practices, increase yields, and reduce production backlogs and work-in-process inventory.

"From NEP's beginnings in 1998, the company has built a culture of continuous improvement," explains Sam Massoni, NEP's founder and senior vice president of science and new technology. Robinson agrees. "A quality system such as one designed to prepare for ISO registration is the logical next step in the evolution of our customer-driven organization. Preparing for ISO 9001: 2008 will place NEP in an elite group in its industry, allowing us to meet demand even more productively with the service and quality our customers around the world have come to expect."

NEP is working with ISO consulting, training and audit firm Global Business Systems of Lunenburg, Mass., to implement the quality program. The company's president, William L. Reynolds, who is an ISO registering quality system lead auditor and certified quality manager, is impressed with NEP's progress. He expects NEP to be ready for ISO registration within nine months.

About ISO (
The International Organization for Standardization (ISO) is the world's largest developer and publisher of international standards. The non-governmental organization's network comprises the national standards institutes of 157 countries, one member per country, with a Central Secretariat in Geneva, Switzerland, that coordinates the system. ISO's 201 technical committees published more than 17,000 international standards and standards-type documents by the end of 2007 for industries ranging from construction to telecommunications.

About New England Peptide, LLC (
New England Peptide, founded in 1998, designs and produces custom peptides and polyclonal antibodies for drug and vaccine discovery organizations worldwide. Headquartered in the Boston metro area in Gardner, Mass., the company's chemists and immunological experts specialize in delivering a full range of services for biotech and pharmaceutical applications.

Peptides are small proteins that play key roles in biochemical regulation of all life systems, helping to fight diseases as diverse as cancer, diabetes, and HIV/AIDS. Peptides' inherent low toxicity and high potency, coupled with improved drug delivery methods and enhanced manufacturing capabilities, are fueling a surge in use. All segments of the peptide market - from therapeutics and vaccines to diagnostics and cosmetics - are thriving.


Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Over and Under(R) Pericardium Covered Stent is now in use in England and Proves Great Deliverability
2. NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
3. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
4. Tandem Labs New England Facility Doubles Discovery Support Capacity - Increasing Foothold in New England
5. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
6. Chromatide and Novasep Have Extended Their Partnership to Develop Large Scale Solid Phase Peptide and Oligonucleotide Synthesis Technology.
7. Nektars PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
8. Teva Pharmaceuticals Altered Peptide Ligand Copaxone Boasts the Greatest Patient Share Among First- and Second-Line Therapies for the Treatment of Multiple Sclerosis
9. ProImmune Launches New MHC-Peptide Binding Assay for Class II HLA Alleles
10. Rice Memorial Hospital Implements SinglePointe(TM) Automated Patient-Specific Management Solution From Omnicell
11. Nastech Pharmaceutical Company Implements Additional Workforce Reduction as Part of Previously Announced Corporate Restructuring
Post Your Comments:
Related Image:
New England Peptide Implements Quality Management System, Prepares for ISO 9001: 2008 Registration
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and ... as Chief Operating Officer. , Having joined InSphero in November 2013 as ... promoted to Head of InSphero Diagnostics in 2014. There she has built up ...
Breaking Biology Technology:
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
(Date:10/27/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... has adopted the Synaptics ® ClearPad ® ... its newest flagship smartphones, the Nexus 5X by LG ... --> --> Synaptics works closely ... collaboration in the joint development of next generation technologies. ...
Breaking Biology News(10 mins):